Trial Site Detail
Drug: |
Dasatinib + Ipilimumab |
|||
|---|---|---|---|---|
Trial: |
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot be Removed by Surgery or Are Metastatic |
|||
| Conditions: | Gastrointestinal Stromal Tumor or Sarcoma | |||
Trial Status: |
Completed |
|||
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
Sandra P. D'Angelo |
|---|---|
Contact: |
Sandra P. D'Angelo 646-888-4159 dangelos@mskcc.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.